The wound contact layer of Ravimus Vet goes on the wound and is made from natural silk nanofibers with a touch of copper and silver nanoparticles. The absorbent layer soaks up moisture and is made from eco-friendly cellulose foam.
Ravimus Vet supports the wound healing process by keeping the right amount of moisture around the wound and absorbing any extra fluids.
For other locations contact email@example.com
1. Dressing conforms to the wound bed
2. Attracts bacteria from the wound cavity
3. Inactivates bacteria on the antibacterial layer
4. Improves the wound healing
We rely on scientifically proven effectiveness of the Ravimus VET. Ravimus wound care technology was developed by scientists and medical doctors as a result of 20 years of research at the National Institute of Chemical Physics and Biophysics, Estonia.
Interview · Anna-Liisa Kubo
Metal Inorganic Nanoparticles and Their Application in Wound Care
Article · Scientific Report Magazine
Synergistic antibacterial effect of copper and silver nanoparticles and their mechanism of action
PhD Thesis · Grigory Vasiliev
Synergistic Mechanisms and Toxicity Profiles of Silver and Copper Nanoparticles for the Development of Novel Antimicrobial Materials
Article · Pharmaceutics Journal
Antibacterial and Antiviral Effects of Ag, Cu and Zn Metals, Respective Nanoparticles and Filter Materials Thereof against Coronavirus SARS-CoV-2 and Influenza A Virus
Article · Springer Link Journal
Surface carboxylation or PEGylation decreases CuO nanoparticles’ cytotoxicity to human cells in vitro without compromising their antibacterial properties
Increased antimicrobial effectiveness (synergy) of silver and copper compounds and medicinal use of their combinations
Most of the Nanordica scientists have pets and they have experienced the sad feeling when an animal has a wound or trauma. An animal with a wound is stressed and traumatized. To help pets recover faster and wounds heal more quickly, they created a wound dressing that minimizes trauma and rapidly repairs the wound.
Olesja Bondarenko, PhD
Chief Executive Officer
Meelis Kadaja, PhD, MBA
Chief Business Officer
Anna-Liisa Kubo, PhD
Chief Innovation Officer
Andres Valkna, PhD
Chief Technology Officer
Einar Kaljuveer, Msc
Mart Roosimaa, MD
Medical Scientific Liaison
Grigory Vasiliev, MD, PhD
Chief Clinical Officer
© 2024 Nanordica Medical OÜ
Register code: 14710113
Billing address: Mäealuse 2/1, Tallinn, Harjumaa 12618, Estonia
We are using cookies on our website because without cookies the entire Internet would not work properly.